Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression

Benedetta Dalla Palma, MD, Valentina Marchica, Fabrizio Accardi, MD, Daniela Guasco, Laura Notarfranchi, MD, Federica Costa, Martina Caviola, Federica De Luca, Luisa Craviotto, MD, Mario Pedrazzoni, MD PhD, Franco Aversa, MD, Nicola Giuliani, MD PhD

Blood (2016) 128 (22): 4452.

https://doi.org/10.1182/blood.V128.22.4452.4452

Published: 2016

Journal Articles

Oncolytic Virotherapy in Multiple Myeloma: A Possible Alternative Role of Bovine Viruses.

Valentina Marchica, Gaetano Donofrio, PhD, Rosanna Vescovini, PhD, Giulia Tebaldi, Alfonso Rosamilia, Daniela Guasco, Paola Storti, PhD, Marina Bolzoni, PhD, Federica Costa, Chiara Schifano, MSc, Sabrina Bonomini, MSc, Fabrizio Accardi, MD, Francesco Piazza, MD, Franco Aversa, MD, Nicola Giuliani, MD PhD

Blood (2016) 128 (22): 2093.

https://doi.org/10.1182/blood.V128.22.2093.2093

Published: 2016

Journal Articles

Overexpression of Pro-Osteoclastogenic Cytokine Receptors and Chemokines By Bone Marrow CD14 + Monocytes of Multiple Myeloma (MM) Patients As Compared to Smoldering MM (SMM) and Monoclonal Gammopathy of Uncertain Significance (MGUS): Role of Interleukin(IL)-21 Receptor/IL-21 Axis in MM-Induced Osteoclastogenesis

Marina Bolzoni, Domenica Ronchetti, Paola Storti, PhD, Daniela Guasco, Valentina Marchica, Luca Agnelli, PhD, Benedetta Dalla Palma, MD, Fabrizio Accardi, MD, Federica Costa, Denise Toscani, Sabrina Bonomini, Benjamin Thomas, PhD, Antonino Neri, Franco Aversa, MD, Nicola Giuliani, MD PhD

Blood (2014) 124 (21): 28.

https://doi.org/10.1182/blood.V124.21.28.28

Published: 2014

Journal Articles

Galectin-1 Is Highly Expressed By Myeloma Cells and the Bone Marrow Microenvironment and Its Suppression Delineates a New Therapeutic in Vitro and in Vivo Strategy in Multiple Myeloma

Paola Storti, PhD, Gaetano Donofrio, PhD, Valentina Marchica, Daniela Guasco, Katia Todoerti, PhD, Irma Airoldi, PhD, Judith Anderson, Marina Bolzoni, Valentina Ferri, Eugenia Martella, MD, Cristina Mancini, MD, Nicoletta Campanini, Antonino Neri, G. David Roodman, MD, PhD, Franco Aversa, MD, Nicola Giuliani, MD PhD

Blood (2014) 124 (21): 3373.

https://doi.org/10.1182/blood.V124.21.3373.3373

Published: 2014

Journal Articles

Myeloma-Induced Osteocyte Death Was Blunted By Proteasome Inhibitors Through The Modulation Of Autophagy

Denise Toscani, Carla Palumbo, MD, Benedetta Dalla Palma, MD, Marina Bolzoni, Marzia Ferretti, Paola Sena, Daniela Guasco, Eugenia Martella, MD, Franco Aversa, MD, Nicola Giuliani, MD, PhD

Blood (2013) 122 (21): 3096.

https://doi.org/10.1182/blood.V122.21.3096.3096

Published: 2013

Journal Articles

IL3 Induces Osteoclastogenesis In Vivo and Is Modulated By Bone Marrow Monocyte / Macrophage Derived Activin A

Rebecca Silbermann, MD, Marina Bolzoni, Paola Storti, PhD, Daniela Guasco, Judith Anderson, Jolene J. Windle, PhD, G. David Roodman, MD, PhD, Nicola Giuliani, MD, PhD

Blood (2013) 122 (21): 3101.

https://doi.org/10.1182/blood.V122.21.3101.3101

Published: 2013

Journal Articles

Relationship Between Presence Of Osteolytic Lesions, Cytogenetic Features and Bone Marrow Levels Of Cytokines and Chemokines In Multiple Myeloma Patients: Role Of Chemokine (C-C motif) Ligand 20

Nicola Giuliani, MD, PhD, Benedetta Dalla Palma, MD, Daniela Guasco, Mario Pedrazzoni, MD, PhD, Marina Bolzoni, Gabriella Sammarelli, PhD, Paola Storti, PhD, Angelica Spolzino, MD, Luisa Craviotto, MD, Massimo De Filippo, MD, Livia Ruffini, MD, Franco Aversa, MD

Blood (2013) 122 (21): 3110.

https://doi.org/10.1182/blood.V122.21.3110.3110

Published: 2013

Journal Articles

Hypoxia-Inducible Factor (HIF)-1a Is A Therapeutic Target in Myeloma-Induced Angiogenesis and Bone Destruction in Vivo .

Marina Bolzoni, Paola Storti, PhD, Gaetano Donofrio, PhD, Irma Airoldi, PhD, Daniela Guasco, Denise Toscani, Marco Peronaci, Eugenia Martella, MD, Mirca Lazzaretti, PhD, Luca Agnelli, PhD, Ken Patrene, Cristina Mancini, MD, Martine Amiot, PhD, Antonino Neri, Simona Colla, Judith Anderson, Franco Aversa, MD, G. David Roodman, MD, PhD, Nicola Giuliani

Blood (2012) 120 (21): 2947.

https://doi.org/10.1182/blood.V120.21.2947.2947

Published: 2012

Journal Articles

Trascriptome Analysis of Bone Marrow CD14 + Monocytes Revealed Differential Expression Profiles in Symptomatic Multiple Myeloma (MM) Compared to Smoldering MM and Monoclonal Gammopathy of Undetermined Significance

Marco Peronaci, Paola Storti, PhD, Domenica Ronchetti, Luca Agnelli, PhD, Marina Bolzoni, Daniela Guasco, Denise Toscani, Benedetta Dalla Palma, MD, Sabrina Bonomini, Gabriella Sammarelli, PhD, Luisa Craviotto, MD, Antonino Neri, Franco Aversa, MD, Nicola Giuliani

Blood (2012) 120 (21): 1811.

https://doi.org/10.1182/blood.V120.21.1811.1811

Published: 2012

Journal Articles

Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients

Denise Toscani, Benedetta Dalla Palma, MD, Carla Palumbo, Marzia Ferretti, Marina Bolzoni, Daniela Guasco, Cristina Mancini, MD, Eugenia Martella, MD, Mirca Lazzaretti, PhD, Mario Pedrazzoni, MD, PhD, Franco Aversa, MD, Nicola Giuliani

Blood (2012) 120 (21): 3978.

https://doi.org/10.1182/blood.V120.21.3978.3978

Published: 2012

Journal Articles

Hypoxia-Inducible Factor (HIF)-1α Is a Therapeutic Target in Myeloma-Induced Angiogenesis

Paola Storti, PhD, Irma Airoldi, PhD, Marina Bolzoni, Mirca Lazzaretti, PhD, Daniela Guasco, Luca Agnelli, PhD, Eugenia Martella, MD, Cristina Mancini, MD, Antonino Neri, MD, Gaetano Donofrio, PhD, Nicola Giuliani, M.D., Ph.D.

Blood (2011) 118 (21): 3927.

https://doi.org/10.1182/blood.V118.21.3927.3927

Published: 2011

Journal Articles

The Activation of Wnt5a-Mediated Non Canonical Wnt Signaling in Human Bone Marrow Osteoprogenitor Cells Increases Osteoblastogenesis and Counterbalances the Inhibitory Effect of Myeloma Cells on Ror2/FZD5 Expression,

Marina Bolzoni, Paola Storti, PhD, Daniela Guasco, Mirca Lazzaretti, PhD, Eugenia Martella, MD, Cristina Mancini, MD, Luca Agnelli, PhD, Sabrina Bonomini, Antonino Neri, MD, Gaetano Donofrio, PhD, Nicola Giuliani, M.D., Ph.D.

Blood (2011) 118 (21): 3928.

https://doi.org/10.1182/blood.V118.21.3928.3928

Published: 2011

NARROW

Bone Marrow DKK-1 Levels in Smoldering Multiple Myeloma Patients: A New Independent Risk Factor for Progression

Oncolytic Virotherapy in Multiple Myeloma: A Possible Alternative Role of Bovine Viruses.

Galectin-1 Is Highly Expressed By Myeloma Cells and the Bone Marrow Microenvironment and Its Suppression Delineates a New Therapeutic in Vitro and in Vivo Strategy in Multiple Myeloma

Myeloma-Induced Osteocyte Death Was Blunted By Proteasome Inhibitors Through The Modulation Of Autophagy

IL3 Induces Osteoclastogenesis In Vivo and Is Modulated By Bone Marrow Monocyte / Macrophage Derived Activin A

Relationship Between Presence Of Osteolytic Lesions, Cytogenetic Features and Bone Marrow Levels Of Cytokines and Chemokines In Multiple Myeloma Patients: Role Of Chemokine (C-C motif) Ligand 20

Hypoxia-Inducible Factor (HIF)-1a Is A Therapeutic Target in Myeloma-Induced Angiogenesis and Bone Destruction in Vivo .

Trascriptome Analysis of Bone Marrow CD14 + Monocytes Revealed Differential Expression Profiles in Symptomatic Multiple Myeloma (MM) Compared to Smoldering MM and Monoclonal Gammopathy of Undetermined Significance

Proteasome Inhibitors Block Myeloma-Induced Osteocyte Death in Vitro and in Vivo in Multiple Myeloma Patients

Hypoxia-Inducible Factor (HIF)-1α Is a Therapeutic Target in Myeloma-Induced Angiogenesis

The Activation of Wnt5a-Mediated Non Canonical Wnt Signaling in Human Bone Marrow Osteoprogenitor Cells Increases Osteoblastogenesis and Counterbalances the Inhibitory Effect of Myeloma Cells on Ror2/FZD5 Expression,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only